107 related articles for article (PubMed ID: 2805071)
1. Identification of a new surface molecule expressed by human LGL and LAK cells production of a specific monoclonal antibody and comparison with other NK/LAK markers.
Zocchi MR; Poggi A; Mariani S; Gianazza E; Rugarli C
Cell Immunol; 1989 Nov; 124(1):144-57. PubMed ID: 2805071
[TBL] [Abstract][Full Text] [Related]
2. LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.
Ferrarini M; Ferrero E; Fortis C; Poggi A; Zocchi MR
Br J Cancer; 1990 Nov; 62(5):754-7. PubMed ID: 1700922
[TBL] [Abstract][Full Text] [Related]
3. A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function.
Zocchi MR; Bottino C; Ferrini S; Moretta L; Moretta A
J Exp Med; 1987 Aug; 166(2):319-26. PubMed ID: 3598463
[TBL] [Abstract][Full Text] [Related]
4. LAK1: a novel leucocyte differentiation antigen shared by lymphoid and endothelial cells.
Zocchi MR; Faravelli A; Gianazza E; Pardi R; Rugarli C
Basic Appl Histochem; 1990; 34(1):43-50. PubMed ID: 2337404
[TBL] [Abstract][Full Text] [Related]
5. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.
Chambers WH; Vujanovic NL; DeLeo AB; Olszowy MW; Herberman RB; Hiserodt JC
J Exp Med; 1989 Apr; 169(4):1373-89. PubMed ID: 2466943
[TBL] [Abstract][Full Text] [Related]
7. Natural killer (NK) cell subsets in the mouse. NK-1.1+/LGL-1+ cells restricted to lysing NK targets, whereas NK-1.1+/LGL-1- cells generate lymphokine-activated killer cells.
Mason LH; Mathieson BJ; Ortaldo JR
J Immunol; 1990 Jul; 145(2):751-9. PubMed ID: 2365999
[TBL] [Abstract][Full Text] [Related]
8. [The effect of corticosteroid on lymphokine-activated killer (LAK) activity and the change of membrane antigen phenotype on PBMC after IL2 incubation with reference to the evaluation in vitro].
Yoshimura A
Nihon Ika Daigaku Zasshi; 1990 Jun; 57(3):211-21. PubMed ID: 2376610
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-activated killer (LAK) cells. VI. NK1.1+, CD3+ LAK effectors are derived from CD4-, CD8-, NK1.1- precursors.
Ballas ZK; Rasmussen W
Cell Immunol; 1991 May; 134(2):296-313. PubMed ID: 1827045
[TBL] [Abstract][Full Text] [Related]
10. Role of CD2 in regulation of CD3- LGL function.
Mason A; Bernard A; Smyth MJ; Ortaldo JR
Eur Cytokine Netw; 1991; 2(1):31-7. PubMed ID: 1714784
[TBL] [Abstract][Full Text] [Related]
11. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
[TBL] [Abstract][Full Text] [Related]
12. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
13. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells.
Roussel E; Gerrard JM; Greenberg AH
Clin Exp Immunol; 1990 Nov; 82(2):416-21. PubMed ID: 1700746
[TBL] [Abstract][Full Text] [Related]
14. LGL-1: a potential triggering molecule on murine NK cells.
Mason LH; Yagita H; Ortaldo JR
J Leukoc Biol; 1994 Mar; 55(3):362-70. PubMed ID: 7509843
[TBL] [Abstract][Full Text] [Related]
15. Further characterization of CD82/IA4 antigen (type III surface protein): an activation/differentiation marker of mononuclear cells.
Lebel-Binay S; Gil ML; Lagaudriere C; Miloux B; Marchiol-Fournigault C; Quillet-Mary A; Lopez M; Fradelizi D; Conjeaud H
Cell Immunol; 1994 Apr; 154(1):468-83. PubMed ID: 7510585
[TBL] [Abstract][Full Text] [Related]
16. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
[TBL] [Abstract][Full Text] [Related]
17. CK226: a novel surface molecule involved in human T cell activation.
Poggi A; Zocchi MR; Moretta L; Moretta A
Eur J Immunol; 1989 Nov; 19(11):2069-74. PubMed ID: 2532139
[TBL] [Abstract][Full Text] [Related]
18. Injury to autologous normal tissues and tumors mediated by lymphokine-activated killer (LAK) cells generated in vitro from peripheral blood mononuclear cells of glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Ohno T
J Hematother; 1999 Feb; 8(1):29-37. PubMed ID: 10192299
[TBL] [Abstract][Full Text] [Related]
19. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
[TBL] [Abstract][Full Text] [Related]
20. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies.
Gil ML; Vita N; Lebel-Binay S; Miloux B; Chalon P; Kaghad M; Marchiol-Fournigault C; Conjeaud H; Caput D; Ferrara P
J Immunol; 1992 May; 148(9):2826-33. PubMed ID: 1573270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
